Anne M Covey1,2, Shahid M Hussain1,2. 1. 1 Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065. 2. 2 Department of Radiology, Stony Brook University Medical Center, Stony Brook, NY.
Abstract
OBJECTIVE: The purposes of this article are to describe the indications, techniques, and results of arterially directed therapies and ablation and to review the imaging assessment of response and complications. CONCLUSION: Most patients with hepatocellular carcinoma are not eligible for surgery, and systemic treatments are suboptimal. Therefore, locoregional therapy plays a large role in this disease. Locoregional therapies include arterially directed therapies, ablation, and radiation therapy.
OBJECTIVE: The purposes of this article are to describe the indications, techniques, and results of arterially directed therapies and ablation and to review the imaging assessment of response and complications. CONCLUSION: Most patients with hepatocellular carcinoma are not eligible for surgery, and systemic treatments are suboptimal. Therefore, locoregional therapy plays a large role in this disease. Locoregional therapies include arterially directed therapies, ablation, and radiation therapy.
Authors: Ju-Ha Kim; Hee Young Kwon; Dong Hoon Ryu; Min-Ho Nam; Bum Sang Shim; Jin Han Kim; Jae Yeol Lee; Sung-Hoon Kim Journal: PLoS One Date: 2017-10-16 Impact factor: 3.240
Authors: Rahul A Sheth; Xiaoxia Wen; Junjie Li; Marites P Melancon; Xin Ji; Y Andrew Wang; Cheng-Hui Hsiao; Diana S-L Chow; Elizabeth M Whitley; Chun Li; Sanjay Gupta Journal: Cancer Nanotechnol Date: 2020-07-01